BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 18974629)

  • 1. Successful treatment of recalcitrant palmoplantar pustular psoriasis with sequential use of infliximab and adalimumab.
    Yawalkar N; Hunger RE
    Dermatology; 2009; 218(1):79-83. PubMed ID: 18974629
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of pustular psoriasis with infliximab.
    Weishaupt C; Metze D; Luger TA; Ständer S
    J Dtsch Dermatol Ges; 2007 May; 5(5):397-9. PubMed ID: 17451384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infliximab-induced remission of extensive plaque psoriasis.
    Amital H; Ingber A; Rubinow A
    Isr Med Assoc J; 2003 Nov; 5(11):827-8. PubMed ID: 14650114
    [No Abstract]   [Full Text] [Related]  

  • 4. Recalcitrant pustular psoriasis successfully treated with adalimumab.
    Alvarez AC; Rodríguez-Nevado I; De Argila D; Rubio FP; Rovira I; Torrelo A; Zambrano A
    Pediatr Dermatol; 2011; 28(2):195-7. PubMed ID: 21504452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Addition of low-dose methotrexate to infliximab in the treatment of a patient with severe, recalcitrant pustular psoriasis.
    Barland C; Kerdel FA
    Arch Dermatol; 2003 Jul; 139(7):949-50. PubMed ID: 12873907
    [No Abstract]   [Full Text] [Related]  

  • 6. Adalimumab treatment for severe recalcitrant chronic plaque psoriasis.
    Ryan C; Kirby B; Collins P; Rogers S
    Clin Exp Dermatol; 2009 Oct; 34(7):784-8. PubMed ID: 19438535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adalimumab treatment is associated with improvement in health-related quality of life in psoriasis: patient-reported outcomes from a phase II randomized controlled trial.
    Shikiar R; Heffernan M; Langley RG; Willian MK; Okun MM; Revicki DA
    J Dermatolog Treat; 2007; 18(1):25-31. PubMed ID: 17365264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sequential therapy in plaque psoriasis using the " Hit and Run " approach: infliximab followed by efalizumab.
    Penz S; Pelletier F; Riou-Gotta MO; Puzenat E; Levang J; Mermet I; Humbert P; Aubin F
    Int J Dermatol; 2012 Feb; 51(2):236-7. PubMed ID: 22250639
    [No Abstract]   [Full Text] [Related]  

  • 9. Life-threatening pustular and erythrodermic psoriasis responding to infliximab.
    Lewis TG; Tuchinda C; Lim HW; Wong HK
    J Drugs Dermatol; 2006 Jun; 5(6):546-8. PubMed ID: 16774108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of infliximab for severe recalcitrant psoriasis after 6 weeks of treatment.
    DE Oliveira JP; Levy A; Morel P; Guibal F
    J Dermatol; 2008 Sep; 35(9):575-80. PubMed ID: 18837702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute treatment of generalized pustular psoriasis of von Zumbusch with single-dose infliximab.
    Smith N; Harms KL; Hines AC; Harms PW; Gudjonsson JE; Hristov AC; Wang F
    J Am Acad Dermatol; 2013 Jun; 68(6):e187-9. PubMed ID: 23680215
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparing treatment outcome of infliximab and adalimumab in patients with severe hidradenitis suppurativa.
    van Rappard DC; Leenarts MF; Meijerink-van 't Oost L; Mekkes JR
    J Dermatolog Treat; 2012 Aug; 23(4):284-9. PubMed ID: 21756155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adalimumab administration after infliximab therapy is a successful treatment strategy for generalized pustular psoriasis.
    Matsumoto A; Komine M; Karakawa M; Kishimoto M; Ohtsuki M
    J Dermatol; 2017 Feb; 44(2):202-204. PubMed ID: 27743397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Our experience with infliximab in reclacitrant cases of psoriasis].
    Pereiro M; González-Vilas D; Sánchez-Aguilar D; Toribio J
    Actas Dermosifiliogr; 2008 Jul; 99 Suppl 4():43-7. PubMed ID: 19080991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of infliximab in the treatment of psoriasis.
    Lee MR; Cooper AJ
    Australas J Dermatol; 2004 Aug; 45(3):193-5. PubMed ID: 15250904
    [No Abstract]   [Full Text] [Related]  

  • 16. Combination of adalimumab with traditional systemic antipsoriatic drugs - a report of 39 cases.
    Philipp S; Wilsmann-Theis D; Weyergraf A; Rotterdam S; Frambach Y; Gerdes S; Mössner R
    J Dtsch Dermatol Ges; 2012 Nov; 10(11):821-37. PubMed ID: 22934607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adalimumab: a new alternative biologic agent for chronic plaque psoriasis.
    Ormerod AD
    Br J Dermatol; 2008 Mar; 158(3):435-6. PubMed ID: 18275521
    [No Abstract]   [Full Text] [Related]  

  • 18. Pustular psoriasis of pregnancy treated with ciclosporin and high-dose prednisolone.
    Edmonds EV; Morris SD; Short K; Bewley SJ; Eady RA
    Clin Exp Dermatol; 2005 Nov; 30(6):709-10. PubMed ID: 16197395
    [No Abstract]   [Full Text] [Related]  

  • 19. Infliximab treatment for psoriasis in 120 patients on therapy for a minimum of one year: a review.
    Kamili QU; Miner A; Hapa A; Menter A
    J Drugs Dermatol; 2011 May; 10(5):539-44. PubMed ID: 21533302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efalizumab rebound response to a sequential therapy of infliximab followed by efalizumab.
    Brunasso AM; Delfino C; Massone C
    Dermatology; 2009; 218(1):73-4. PubMed ID: 18841002
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.